SRRA
Geode Capital Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-137,385
| Closed | -$7.56M | – | 5106 |
|
2022
Q2 | $7.56M | Buy |
137,385
+125,583
| +1,064% | +$6.91M | ﹤0.01% | 2447 |
|
2022
Q1 | $378K | Buy |
11,802
+1,727
| +17% | +$55.3K | ﹤0.01% | 4080 |
|
2021
Q4 | $219K | Hold |
10,075
| – | – | ﹤0.01% | 4437 |
|
2021
Q3 | $220K | Buy |
+10,075
| New | +$220K | ﹤0.01% | 4412 |
|
2020
Q1 | – | Sell |
-48,539
| Closed | -$16K | – | 4213 |
|
2019
Q4 | $16K | Hold |
48,539
| – | – | ﹤0.01% | 4175 |
|
2019
Q3 | $18K | Hold |
48,539
| – | – | ﹤0.01% | 4158 |
|
2019
Q2 | $27K | Buy |
48,539
+13,174
| +37% | +$7.33K | ﹤0.01% | 4143 |
|
2019
Q1 | $60K | Hold |
35,365
| – | – | ﹤0.01% | 3986 |
|
2018
Q4 | $46K | Hold |
35,365
| – | – | ﹤0.01% | 4005 |
|
2018
Q3 | $60K | Hold |
35,365
| – | – | ﹤0.01% | 4011 |
|
2018
Q2 | $104K | Hold |
35,365
| – | – | ﹤0.01% | 3860 |
|
2018
Q1 | $73K | Hold |
35,365
| – | – | ﹤0.01% | 3902 |
|
2017
Q4 | $131K | Hold |
35,365
| – | – | ﹤0.01% | 3763 |
|
2017
Q3 | $54K | Hold |
35,365
| – | – | ﹤0.01% | 3926 |
|
2017
Q2 | $41K | Sell |
35,365
-3,488
| -9% | -$4.04K | ﹤0.01% | 3986 |
|
2017
Q1 | $59K | Buy |
38,853
+25,342
| +188% | +$38.5K | ﹤0.01% | 3921 |
|
2016
Q4 | $20K | Buy |
13,511
+316
| +2% | +$468 | ﹤0.01% | 4002 |
|
2016
Q3 | $24K | Buy |
13,195
+79
| +0.6% | +$144 | ﹤0.01% | 3985 |
|
2016
Q2 | $26K | Hold |
13,116
| – | – | ﹤0.01% | 4004 |
|
2016
Q1 | $88 | Buy |
13,116
+2,336
| +22% | +$16 | ﹤0.01% | 3865 |
|
2015
Q4 | $162K | Buy |
10,780
+158
| +1% | +$2.37K | ﹤0.01% | 3753 |
|
2015
Q3 | $217K | Buy |
+10,622
| New | +$217K | ﹤0.01% | 3655 |
|